Combined clemastine fumarate and selenomethionine promote remyelination via PI3K/Akt/mTOR signaling in experimental multiple sclerosis. Singh R K, Mehan S Naunyn Schmiedebergs Arch Pharmacol. 2026 Aug 20. PMID: 42622843. Abstract CommentRecommendBookmarkWatch
